Orthofix Medical Inc. (OFIX) intrinsic value & 10-year financials
Orthofix Medical Inc. (OFIX) has a Graham intrinsic value of $2.75 per share. At $9.38 on Oct 17, 2026, the stock trades 241% above that value. Over the last 10 fiscal years revenue grew 8.1% a year to $822.3M, with an average return on invested capital of -5.3%.
- Graham intrinsic value
- $2.75
- Share price (Oct 17, 2026)
- $9.38
- Price vs Graham value
- 241% above
- Market cap
- $371.5M
- Revenue (FY2025)
- $822.3M
- Revenue growth (10-yr CAGR)
- 8.1%
- ROIC (10-yr avg)
- -5.3%
- Free cash flow (FY2025)
- -$1.3M
OFIX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $822.3M | -$92.2M | -$2.33 | -$1.3M | -9.9% | -13.8% |
| FY2024 | $799.5M | -$126.0M | -$3.30 | -$9.1M | -10.6% | -13.0% |
| FY2023 | $746.6M | -$151.4M | -$4.12 | -$106.0M | -18.6% | -27.6% |
| FY2022 | $460.7M | -$19.7M | -$0.98 | -$32.9M | -2.9% | -4.6% |
| FY2021 | $464.5M | -$38.4M | -$1.95 | $690.0K | -1.8% | -3.0% |
| FY2020 | $406.6M | $2.5M | $0.13 | $58.8M | -1.5% | -1.1% |
| FY2019 | $460.0M | -$28.5M | -$1.51 | $13.0M | -4.1% | -6.6% |
| FY2018 | $453.0M | $13.8M | $0.72 | $36.3M | 6.6% | 5.7% |
| FY2017 | $433.8M | $6.2M | $0.34 | $38.7M | 9.4% | 7.3% |
| FY2016 | $409.8M | $3.1M | $0.17 | $28.3M | 5.1% | 4.0% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Orthofix Medical Inc. has demonstrated mature, steady growth, with revenue compounding at 8.0% annually over the past decade.
Orthofix Medical Inc. has historically struggled to out-earn its cost of capital, averaging just -5.3% ROIC.
Orthofix Medical Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Orthofix Medical Inc. is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $2.75 per share.